Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT03479671
EARLY_PHASE1

Low Dose Fat-Induced Insulin Resistance

Sponsor: University of Pennsylvania

View on ClinicalTrials.gov

Summary

The primary goal of this study is to determine the dose of fatty acids that acutely induces mild insulin resistance in healthy volunteers. We hypothesize that a low-dose of fatty acid infusion (Intralipid/heparin) will cause a mild insulin resistance. The dose of fatty acid infusion that reliably causes mild insulin resistance will be selected for use in future studies.

Official title: A Dose Finding Study for Fat-Induced Insulin Resistance in Healthy Volunteers

Key Details

Gender

All

Age Range

18 Years - 44 Years

Study Type

INTERVENTIONAL

Enrollment

9

Start Date

2020-01-01

Completion Date

2024-11-19

Last Updated

2026-04-15

Healthy Volunteers

Yes

Interventions

DRUG

Intralipid, 20% Intravenous Emulsion

Fatty Acid Infusion, either in low-dose (30 ml/hr) or medium-dose (60 ml/hr)

Locations (1)

University of Pennsylvania

Philadelphia, Pennsylvania, United States